| New insights into the genetic etiology of Alzheimer’s disease and related dementias C Bellenguez, F Küçükali, IE Jansen, L Kleineidam, S Moreno-Grau, ... Nature genetics 54 (4), 412-436, 2022 | 974 | 2022 |
| Common variants in Alzheimer’s disease and risk stratification by polygenic risk scores I de Rojas, S Moreno-Grau, N Tesi, B Grenier-Boley, V Andrade, ... Nature communications 12 (1), 1-16, 2021 | 187 | 2021 |
| Prevalence Estimates of Amyloid Abnormality Across the Alzheimer Disease Clinical Spectrum WJ Jansen, O Janssen, BM Tijms, SJB Vos, R Ossenkoppele, PJ Visser, ... JAMA neurology, 2022 | 121 | 2022 |
| Severely impaired hippocampal neurogenesis associates with an early serotonergic deficit in a BAC α-synuclein transgenic rat model of Parkinson's disease Z Kohl, NB Abdallah, J Vogelgsang, L Tischer, J Deusser, D Amato, ... Neurobiology of disease 85, 206-217, 2016 | 97 | 2016 |
| A two-step immunoassay for the simultaneous assessment of Aβ38, Aβ40 and Aβ42 in human blood plasma supports the Aβ42/Aβ40 ratio as a promising biomarker candidate of Alzheimer … H Shahpasand-Kroner, HW Klafki, C Bauer, J Schuchhardt, ... Alzheimer's research & therapy 10 (1), 121, 2018 | 55 | 2018 |
| Genome-wide meta-analysis for Alzheimer′ s disease cerebrospinal fluid biomarkers IE Jansen, SJ van der Lee, D Gomez-Fonseca, I de Rojas, MC Dalmasso, ... medRxiv, 2022 | 46 | 2022 |
| Autoantibody-associated psychiatric symptoms and syndromes in adults: A narrative review and proposed diagnostic approach N Hansen, M Lipp, J Vogelgsang, R Vukovich, T Zindler, D Luedecke, ... Brain, Behavior, & Immunity-Health 9, 100154, 2020 | 40 | 2020 |
| S1 guidelines “lumbar puncture and cerebrospinal fluid analysis”(abridged and translated version) H Tumani, HF Petereit, A Gerritzen, CC Gross, A Huss, S Isenmann, ... Neurological Research and Practice 2 (1), 1-28, 2020 | 36 | 2020 |
| Multiplex immunoassay measurement of amyloid-β42 to amyloid-β40 ratio in plasma discriminates between dementia due to Alzheimer’s disease and dementia … J Vogelgsang, H Shahpasand-Kroner, R Vogelgsang, F Streit, R Vukovich, ... Experimental brain research 236 (5), 1241-1250, 2018 | 36 | 2018 |
| Clinical reporting following the quantification of cerebrospinal fluid biomarkers in Alzheimer's disease: An international overview C Delaby, CE Teunissen, K Blennow, D Alcolea, I Arisi, EB Amar, ... Alzheimer's & Dementia 17, e057528, 2021 | 34 | 2021 |
| CSF and blood Kallikrein-8: a promising early biomarker for Alzheimer’s disease S Teuber-Hanselmann, J Rekowski, J Vogelgsang, C von Arnim, K Reetz, ... Journal of Neurology, Neurosurgery & Psychiatry 91 (1), 40-48, 2020 | 31 | 2020 |
| Evolution of psychosocial burden and psychiatric symptoms in patients with psychiatric disorders during the Covid-19 pandemic M Belz, P Hessmann, J Vogelgsang, U Schmidt, M Ruhleder, ... European archives of psychiatry and clinical neuroscience 272 (1), 29-40, 2022 | 28 | 2022 |
| Potential of FTIR Spectroscopy applied to exosomes for Alzheimer’s disease discrimination: A pilot study T Soares Martins, S Magalhães, IM Rosa, J Vogelgsang, J Wiltfang, ... Journal of Alzheimer's Disease 74 (1), 391-405, 2020 | 27 | 2020 |
| Cardiovascular and metabolic comorbidities in patients with Alzheimer's disease and vascular dementia compared to a psychiatric control cohort J Vogelgsang, C Wolff‐Menzler, B Kis, M Abdel‐Hamid, J Wiltfang, ... Psychogeriatrics 18 (5), 393-401, 2018 | 27 | 2018 |
| Medium-term and peri-lockdown course of psychosocial burden during the ongoing COVID-19 pandemic: a longitudinal study on patients with pre-existing mental disorders C Bartels, P Hessmann, U Schmidt, J Vogelgsang, M Ruhleder, ... European archives of psychiatry and clinical neuroscience 272 (5), 757-771, 2022 | 24 | 2022 |
| Comparison between amyloid-PET and CSF amyloid-β biomarkers in a clinical cohort with memory deficits C Bouter, J Vogelgsang, J Wiltfang Clinica Chimica Acta 492, 62-68, 2019 | 23 | 2019 |
| Validation of a prototype tau Thr231 phosphorylation CSF ELISA as a potential biomarker for Alzheimer’s disease JRF Santos, C Bauer, J Schuchhardt, D Wedekind, K Waniek, I Lachmann, ... Journal of Neural Transmission 126 (3), 339-348, 2019 | 21 | 2019 |
| Reproducibility of Alzheimer’s disease cerebrospinal fluid-biomarker measurements under clinical routine conditions J Vogelgsang, D Wedekind, C Bouter, HW Klafki, J Wiltfang Journal of Alzheimer's Disease 62 (1), 203-212, 2018 | 21 | 2018 |
| Novel Exosome Biomarker Candidates for Alzheimer’s Disease Unravelled Through Mass Spectrometry Analysis T Soares Martins, R Marçalo, CB da Cruz e Silva, D Trindade, J Catita, ... Molecular Neurobiology 59 (5), 2838-2854, 2022 | 20 | 2022 |
| Serum neurofilament light chain (NFL) remains unchanged during electroconvulsive therapy M Besse, M Belz, T Folsche, J Vogelgsang, I Methfessel, P Steinacker, ... The World Journal of Biological Psychiatry 21 (2), 148-154, 2020 | 20 | 2020 |
